BioNexus Gene Lab Corp. (BGLC)

NASDAQ: BGLC · Real-Time Price · USD

1.370

-0.140 (-9.27%)

At close: Jul 27, 2026, 4:00 PM EDT

1.360

-0.010 (-0.73%)

After-hours: Jul 27, 2026, 4:20 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Trading of Industrial Chemicals	7.41M	9.49M	9.75M	10.83M	11.85M
Provision for Genomic Screening Services	19.09K	16.07K	24.22K	95.82K	1.52M
Total	7.42M	9.51M	9.77M	10.93M	13.36M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Malaysia	5.83M	7.46M	8.22M	-	-
Maldives	680.99K	762.14K	637.19K	-	-
Singapore	240.76K	572.03K	244.40K	-	-
Sri Lanka	452.64K	459.00K	87.03K	-	-
Bangladesh	106.25K	123.27K	538.06K	-	-
Indonesia	114.87K	138.30K	-	-	-
Nigeria	-	-	42.07K	-	-
Total	7.42M	9.51M	9.77M	-	-